Identification of cylin-dependent kinase 1 inhibitors of a new chemical type by structure-based design and database searching
Authors:
- 1 May 2001
- journal article
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 15 (5) , 489-495
Abstract
We have selected cyclin-dependent kinase 1 (CDK1), an enzyme participating in the regulation of the cell cycle, as a target in our efforts to discover new antitumor agents. By exploiting available...Keywords
This publication has 23 references indexed in Scilit:
- Inhibition of Cyclin-Dependent Kinase 4 (Cdk4) by Fascaplysin, a Marine Natural ProductBiochemical and Biophysical Research Communications, 2000
- The cell cycle and drug discovery: the promise and the hopeDrug Discovery Today, 1999
- The therapeutic potential of targeting the cell cycleExpert Opinion on Investigational Drugs, 1998
- CYCLIN-DEPENDENT KINASES: Engines, Clocks, and MicroprocessorsAnnual Review of Cell and Developmental Biology, 1997
- Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.Proceedings of the National Academy of Sciences, 1996
- Multiple modes of ligand recognition: Crystal structures of cyclin‐dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenineProteins: Structure, Function, and Bioinformatics, 1995
- Inhibition of Cyclin‐Dependent Kinases by Purine AnaloguesEuropean Journal of Biochemistry, 1994
- Purification and Crystallization of Human Cyclin-dependent Kinase 2Journal of Molecular Biology, 1993
- ANIMAL CELL CYCLES AND THEIR CONTROLAnnual Review of Biochemistry, 1992
- A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activityInternational Journal of Cancer, 1989